Posts

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved nearly $42 million to fund 19 new studies comparing which healthcare approaches work best.

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today authorized making up to $50 million available for studies comparing non-surgical interventions for the treatment of chronic low back pain through a new PCORI Funding Announcement (PFA).

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved $14.8 million to fund a study of two newer blood-thinning medications. The study will compare the two drugs against each other and against the older drug warfarin to see which works best in preventing the recurrence of dangerous blood clots in the veins and lungs.

The Patient-Centered Outcomes Research Institute (PCORI) this week welcomes two new Board of Governors members—Russell Howerton, MD, Chief Medical Officer and Vice President of Clinical Operations at Wake Forest Baptist Medical Center, and Kathleen Troeger, MPH, Director of Outcomes Research at Hologic, Inc.

The Patient-Centered Outcomes Research Institute (PCORI) has issued 10 new announcements offering up to $351 million in funding for patient-centered comparative clinical effectiveness research (CER) study proposals.

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved the selection or reappointment of 48 people to serve on PCORI’s seven multi-stakeholder advisory panels. This includes 41 new candidates chosen from more than 400 people, who either nominated themselves or were nominated by third parties.

The Patient-Centered Outcomes Research Institute (PCORI) has awarded funds totaling $688,000 for 46 projects through its "Pipeline to Proposal" Awards program.

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved nearly $21 million to fund two studies to help determine the most effective ways to manage and reduce opioid use among people with chronic pain.

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved nearly $40 million to fund three studies that will compare the effectiveness of different strategies for improving care and outcomes for people with treatment-resistant depression.

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved nearly $20 million to fund four comparative clinical effectiveness research (CER) studies that will assess several therapies used to treat multiple sclerosis (MS) or its symptoms.

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved $152.8 million to fund 28 comparative clinical effectiveness research (CER) studies and seven related projects for improving CER methods.

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved $6.5 million to fund two studies that will compare the effectiveness of the newer as well as older blood-thinning medications in preventing dangerous blood clots in the veins and lungs.

Research proposals on the comparative effectiveness of long-term opioid use for chronic pain, the blood clot dissolving drugs, therapies for multiple sclerosis, and strategies for treatment-resistant depression are among the studies that will be considered for funding by the Patient-Centered Outcomes Research Institute (PCORI) Board of Governors at its next meeting.

The Patient-Centered Outcomes Research Institute (PCORI) has awarded funds totaling nearly $1.2 million to enable 22 projects to advance into the final phase of PCORI’s "Pipeline to Proposal" Awards program.

The Patient-Centered Outcomes Research Institute (PCORI) today announced its support of Vice President Joe Biden’s Cancer Moonshot program to accelerate progress in cancer research and care.

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved nearly $9 million for two projects designed to show how health plans can partner with PCORnet’s Clinical Data Research Networks (CDRNs) to capture health plan data, especially from claims and membership records, to support the network’s goal of speeding research that can help patients and those who care for them make better-informed healthcare decisions.

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved more than $20 million to fund four new patient-centered comparative clinical effectiveness research (CER) studies.

The Patient-Centered Outcomes Research Institute (PCORI) today welcomed Andrew Bindman, MD, the newly named Director of the Agency for Healthcare Research and Quality (AHRQ), to PCORI’s Board of Governors.

The Patient-Centered Outcomes Research Institute (PCORI) has awarded funds totaling nearly $1.1 million to enable 44 projects that were awarded Tier I support through its "Pipeline to Proposal" Awards program to move forward into the program’s second phase.

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved $44.4 million in funding for 21 new patient-centered comparative clinical effectiveness research (CER) studies.

The Patient-Centered Outcomes Research Institute (PCORI) today announced a new policy that will facilitate free and ready public access to the published findings of PCORI-funded comparative clinical effectiveness research (CER) studies.

Evidence-based medicine holds significant potential to enhance the quality of health care and improve patients’ outcomes. But how do the ultimate decision-makers and end users of healthcare services — patients and their caregivers — receive and use medical evidence?

The Patient-Centered Outcomes Research Institute (PCORI) has partnered with the Centers for Disease Control and Prevention (CDC), and National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to launch a new research network focused on diabetes.

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today authorized providing up to $22 million to study ways to improve treatment of chronic low back pain, a leading cause of disability and one of the most frequent reasons adults seek medical care. Additionally, the Board approved $12.5 million for five Patient-Powered Research Network (PPRN) demonstration projects.

The Patient-Centered Outcomes Research Institute (PCORI) today welcomed Sharon Arnold, PhD, newly named Acting Director of the Agency for Healthcare Research and Quality (AHRQ), to PCORI’s Board of Governors. PCORI also thanked outgoing AHRQ Director Richard Kronick, PhD, for his service as a Board member.